GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (OTCPK:AINMF) » Definitions » Capex-to-Revenue

AINMF (NetraMark Holdings) Capex-to-Revenue : 0.00 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NetraMark Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

NetraMark Holdings's Capital Expenditure for the three months ended in Dec. 2024 was $0.00 Mil. Its Revenue for the three months ended in Dec. 2024 was $0.27 Mil.

Hence, NetraMark Holdings's Capex-to-Revenue for the three months ended in Dec. 2024 was 0.00.

NetraMark Holdings Capex-to-Revenue Historical Data

The historical data trend for NetraMark Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetraMark Holdings Capex-to-Revenue Chart

NetraMark Holdings Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Capex-to-Revenue
- - 1.34 - -

NetraMark Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NetraMark Holdings's Capex-to-Revenue

For the Health Information Services subindustry, NetraMark Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NetraMark Holdings's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where NetraMark Holdings's Capex-to-Revenue falls into.


;
;

NetraMark Holdings Capex-to-Revenue Calculation

NetraMark Holdings's Capex-to-Revenue for the fiscal year that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.337
=0.00

NetraMark Holdings's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.271
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NetraMark Holdings  (OTCPK:AINMF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

NetraMark Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of NetraMark Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

NetraMark Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (OTCPK:AINMF) » Definitions » Capex-to-Revenue
Comparable Companies
NEOE:ALGO TSXV:NURS TSXV:ADK XCNQ:UDOC XCNQ:TRUE XCNQ:AIML XCNQ:MOSS TSXV:KOVO TSXV:AJA XCNQ:DMED VEEV GEHC ASX:PME DOCS TEM TSE:2413 HQY WAY SZSE:300253 HKSE:02228
Traded in Other Exchanges
PF0:Germany AIAI:Canada
Address
1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1
Website
https://www.netramark.com
NetraMark Holdings Inc is focused on the application of an Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.